505 related articles for article (PubMed ID: 36268225)
1. Overrepresentation of Enterobacteriaceae and
Khorsand B; Asadzadeh Aghdaei H; Nazemalhosseini-Mojarad E; Nadalian B; Nadalian B; Houri H
Front Cell Infect Microbiol; 2022; 12():1015890. PubMed ID: 36268225
[TBL] [Abstract][Full Text] [Related]
2. Gut microbiota differs between children with Inflammatory Bowel Disease and healthy siblings in taxonomic and functional composition: a metagenomic analysis.
Knoll RL; Forslund K; Kultima JR; Meyer CU; Kullmer U; Sunagawa S; Bork P; Gehring S
Am J Physiol Gastrointest Liver Physiol; 2017 Apr; 312(4):G327-G339. PubMed ID: 28039159
[TBL] [Abstract][Full Text] [Related]
3. Diagnosis of Crohn's disease and ulcerative colitis using the microbiome.
Kang DY; Park JL; Yeo MK; Kang SB; Kim JM; Kim JS; Kim SY
BMC Microbiol; 2023 Nov; 23(1):336. PubMed ID: 37951857
[TBL] [Abstract][Full Text] [Related]
4. High prevalence of Mucosa-Associated extended-spectrum β-Lactamase-producing Escherichia coli and Klebsiella pneumoniae among Iranain patients with inflammatory bowel disease (IBD).
Kharaghani AA; Harzandi N; Khorsand B; Rajabnia M; Kharaghani AA; Houri H
Ann Clin Microbiol Antimicrob; 2023 Sep; 22(1):86. PubMed ID: 37710309
[TBL] [Abstract][Full Text] [Related]
5. Gut microbiota in mucosa and feces of newly diagnosed, treatment-naïve adult inflammatory bowel disease and irritable bowel syndrome patients.
Čipčić Paljetak H; Barešić A; Panek M; Perić M; Matijašić M; Lojkić I; Barišić A; Vranešić Bender D; Ljubas Kelečić D; Brinar M; Kalauz M; Miličević M; Grgić D; Turk N; Karas I; Čuković-Čavka S; Krznarić Ž; Verbanac D
Gut Microbes; 2022; 14(1):2083419. PubMed ID: 35695669
[TBL] [Abstract][Full Text] [Related]
6. Gut microbiome structure and metabolic activity in inflammatory bowel disease.
Franzosa EA; Sirota-Madi A; Avila-Pacheco J; Fornelos N; Haiser HJ; Reinker S; Vatanen T; Hall AB; Mallick H; McIver LJ; Sauk JS; Wilson RG; Stevens BW; Scott JM; Pierce K; Deik AA; Bullock K; Imhann F; Porter JA; Zhernakova A; Fu J; Weersma RK; Wijmenga C; Clish CB; Vlamakis H; Huttenhower C; Xavier RJ
Nat Microbiol; 2019 Feb; 4(2):293-305. PubMed ID: 30531976
[TBL] [Abstract][Full Text] [Related]
7. The oral-gut axis: Salivary and fecal microbiome dysbiosis in patients with inflammatory bowel disease.
Abdelbary MMH; Hatting M; Bott A; Dahlhausen A; Keller D; Trautwein C; Conrads G
Front Cell Infect Microbiol; 2022; 12():1010853. PubMed ID: 36275026
[TBL] [Abstract][Full Text] [Related]
8. Gut-derived Enterococcus faecium from ulcerative colitis patients promotes colitis in a genetically susceptible mouse host.
Seishima J; Iida N; Kitamura K; Yutani M; Wang Z; Seki A; Yamashita T; Sakai Y; Honda M; Yamashita T; Kagaya T; Shirota Y; Fujinaga Y; Mizukoshi E; Kaneko S
Genome Biol; 2019 Nov; 20(1):252. PubMed ID: 31767028
[TBL] [Abstract][Full Text] [Related]
9. Escherichia coli Strains from Patients with Inflammatory Bowel Diseases have Disease-specific Genomic Adaptations.
Dubinsky V; Reshef L; Rabinowitz K; Wasserberg N; Dotan I; Gophna U
J Crohns Colitis; 2022 Nov; 16(10):1584-1597. PubMed ID: 35560165
[TBL] [Abstract][Full Text] [Related]
10. Dysbiosis in the Gut Microbiota in Patients with Inflammatory Bowel Disease during Remission.
Pisani A; Rausch P; Bang C; Ellul S; Tabone T; Marantidis Cordina C; Zahra G; Franke A; Ellul P
Microbiol Spectr; 2022 Jun; 10(3):e0061622. PubMed ID: 35532243
[TBL] [Abstract][Full Text] [Related]
11. Two-Sample Mendelian Randomization Analysis Investigates Causal Associations Between Gut Microbial Genera and Inflammatory Bowel Disease, and Specificity Causal Associations in Ulcerative Colitis or Crohn's Disease.
Liu B; Ye D; Yang H; Song J; Sun X; Mao Y; He Z
Front Immunol; 2022; 13():921546. PubMed ID: 35860271
[TBL] [Abstract][Full Text] [Related]
12. Fecal microbial dysbiosis in Chinese patients with inflammatory bowel disease.
Ma HQ; Yu TT; Zhao XJ; Zhang Y; Zhang HJ
World J Gastroenterol; 2018 Apr; 24(13):1464-1477. PubMed ID: 29632427
[TBL] [Abstract][Full Text] [Related]
13. Bacterial bile metabolising gene abundance in Crohn's, ulcerative colitis and type 2 diabetes metagenomes.
Labbé A; Ganopolsky JG; Martoni CJ; Prakash S; Jones ML
PLoS One; 2014; 9(12):e115175. PubMed ID: 25517115
[TBL] [Abstract][Full Text] [Related]
14. Antibody responses to gut bacteria in ankylosing spondylitis, rheumatoid arthritis, Crohn's disease and ulcerative colitis.
Tiwana H; Wilson C; Walmsley RS; Wakefield AJ; Smith MS; Cox NL; Hudson MJ; Ebringer A
Rheumatol Int; 1997; 17(1):11-6. PubMed ID: 9194209
[TBL] [Abstract][Full Text] [Related]
15. Alterations of mucosal microbiota in the colon of patients with inflammatory bowel disease revealed by real time polymerase chain reaction amplification of 16S ribosomal ribonucleic acid.
Kabeerdoss J; Jayakanthan P; Pugazhendhi S; Ramakrishna BS
Indian J Med Res; 2015 Jul; 142(1):23-32. PubMed ID: 26261163
[TBL] [Abstract][Full Text] [Related]
16. Siderophore Immunization Restricted Colonization of Adherent-Invasive Escherichia coli and Ameliorated Experimental Colitis.
Gerner RR; Hossain S; Sargun A; Siada K; Norton GJ; Zheng T; Neumann W; Nuccio SP; Nolan EM; Raffatellu M
mBio; 2022 Oct; 13(5):e0218422. PubMed ID: 36094114
[TBL] [Abstract][Full Text] [Related]
17. Metaproteomics of fecal samples of Crohn's disease and Ulcerative Colitis.
Lehmann T; Schallert K; Vilchez-Vargas R; Benndorf D; Püttker S; Sydor S; Schulz C; Bechmann L; Canbay A; Heidrich B; Reichl U; Link A; Heyer R
J Proteomics; 2019 Jun; 201():93-103. PubMed ID: 31009805
[TBL] [Abstract][Full Text] [Related]
18. The Roles of Inflammation, Nutrient Availability and the Commensal Microbiota in Enteric Pathogen Infection.
Stecher B
Microbiol Spectr; 2015 Jun; 3(3):. PubMed ID: 26185088
[TBL] [Abstract][Full Text] [Related]
19. Metagenomic analysis of intestinal mucosa revealed a specific eukaryotic gut virome signature in early-diagnosed inflammatory bowel disease.
Ungaro F; Massimino L; Furfaro F; Rimoldi V; Peyrin-Biroulet L; D'Alessio S; Danese S
Gut Microbes; 2019; 10(2):149-158. PubMed ID: 30252582
[TBL] [Abstract][Full Text] [Related]
20. Intestinal Taxa Abundance and Diversity in Inflammatory Bowel Disease Patients: An Analysis including Covariates and Confounders.
Teofani A; Marafini I; Laudisi F; Pietrucci D; Salvatori S; Unida V; Biocca S; Monteleone G; Desideri A
Nutrients; 2022 Jan; 14(2):. PubMed ID: 35057440
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
